Matches in Wikidata for { <http://www.wikidata.org/entity/Q81638797> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q81638797 description "2005 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված" @default.
- Q81638797 description "article scientifique publié en 2005" @default.
- Q81638797 description "artículu científicu espublizáu n'abril de 2005" @default.
- Q81638797 description "scientific article published on 11 April 2005" @default.
- Q81638797 description "wetenschappelijk artikel" @default.
- Q81638797 description "наукова стаття, опублікована у квітні 2005" @default.
- Q81638797 name "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 name "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 type Item @default.
- Q81638797 label "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 label "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 prefLabel "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 prefLabel "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 P1433 Q81638797-097502FE-2B82-4594-BFC1-A53B517CD10D @default.
- Q81638797 P1476 Q81638797-19098DC8-BE38-4E30-A6DF-C34EC800D52F @default.
- Q81638797 P2093 Q81638797-080A350B-0016-43CB-9590-C6171AF6AF24 @default.
- Q81638797 P2093 Q81638797-0928A7DF-AC8B-4010-9E48-E5B43243861B @default.
- Q81638797 P2093 Q81638797-24DC9DD4-04E5-4F8A-97E9-F3F3883118E0 @default.
- Q81638797 P2093 Q81638797-28FEF90D-954D-49BE-9101-FE026A799C22 @default.
- Q81638797 P2093 Q81638797-870AE8C0-76C9-4852-891F-A53695DE29A3 @default.
- Q81638797 P2093 Q81638797-8FA8AC9A-FB7D-44B5-9945-6B529DF6030E @default.
- Q81638797 P2093 Q81638797-C4A39CFD-DE74-4F6B-9BC1-F4DD1CE0136A @default.
- Q81638797 P2093 Q81638797-EF86EDCE-7D8B-4E3A-81EF-3377380CB596 @default.
- Q81638797 P304 Q81638797-5BCA09CF-5E2E-4E35-981B-B33F95F5F6F4 @default.
- Q81638797 P31 Q81638797-CBB0769F-8A73-4A33-969C-6A8FC2D4E087 @default.
- Q81638797 P356 Q81638797-14641658-0A45-4AC5-81EE-A6B819FFC484 @default.
- Q81638797 P433 Q81638797-85BEA8B8-AE00-4985-B1EB-ECDBC4A6BDEC @default.
- Q81638797 P478 Q81638797-6110E552-3570-47BB-9BBE-0B2759B9CF84 @default.
- Q81638797 P50 Q81638797-AAFCBD11-6B50-45F8-AB63-803666D8789D @default.
- Q81638797 P577 Q81638797-BE16CB8E-146A-465D-A468-F6190A0256BF @default.
- Q81638797 P698 Q81638797-680AE85C-2742-4273-88BE-B1409D6AD9CF @default.
- Q81638797 P356 MDI178 @default.
- Q81638797 P698 15824081 @default.
- Q81638797 P1433 Q326122 @default.
- Q81638797 P1476 "A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors" @default.
- Q81638797 P2093 "A A Desai" @default.
- Q81638797 P2093 "A Young" @default.
- Q81638797 P2093 "J A Wright" @default.
- Q81638797 P2093 "L Janisch" @default.
- Q81638797 P2093 "N J Vogelzang" @default.
- Q81638797 P2093 "R L Schilsky" @default.
- Q81638797 P2093 "S Cadden" @default.
- Q81638797 P2093 "W M Stadler" @default.
- Q81638797 P304 "958-965" @default.
- Q81638797 P31 Q13442814 @default.
- Q81638797 P356 "10.1093/ANNONC/MDI178" @default.
- Q81638797 P433 "6" @default.
- Q81638797 P478 "16" @default.
- Q81638797 P50 Q87725760 @default.
- Q81638797 P577 "2005-04-11T00:00:00Z" @default.
- Q81638797 P698 "15824081" @default.